Percutaneous Transhepatic Papillary Balloon Dilation versus Endoscopic Retrograde Cholangiopancreatography for Common Bile Duct Stones: A Multicenter Prospective Study.
Liu B, Ma J, Li S, Li C, Qi H, Nian D, Yin C, Zhu J, Wang C, Jia Y, Jiang T, Lu J, Wang L, Shen D, Hou X, Li D, Zhang Z, Du F, Wu H, Yu T, Li Y.
Radiology. 2021 Aug;300(2):470-478. doi: 10.1148/radiol.2021201115. Epub 2021 Jun 1.
Percutaneous transcystic balloon dilation for common bile duct stone removal in high-surgical-risk patients with acute cholecystitis and co-existing choledocholithiasis.
Wang W, Wang C, Qi H, Wang Y, Li Y.
HPB (Oxford). 2018 Apr;20(4):327-331. doi: 10.1016/j.hpb.2017.10.002. Epub 2017 Nov 13.
[Diagnosis and treatment standardizations on percutaneous transhepatic papillary balloon dilation for common bile duct stones].
Interventional Physician Branch of Chinese Medical Doctor Association.
Zhonghua Nei Ke Za Zhi. 2022 Mar 1;61(3):263-268. doi: 10.3760/cma.j.cn112138-20210823-00578.
Comparing percutaneous transhepatic papillary balloon dilation with endoscopic retrograde cholangiopancreatography in elderly patients for common bile duct stones: a 3-year retrospective study.
Wang ZX, Liu FL, Li L.
Abdom Radiol (NY). 2024 Aug;49(8):2706-2713. doi: 10.1007/s00261-024-04371-z. Epub 2024 May 25.
Ursodeoxycholic acid combined with percutaneous transhepatic balloon dilation for management of gallstones after elimination of common bile duct stones.
Chang HY, Wang CJ, Liu B, Wang YZ, Wang WJ, Wang W, Li D, Li YL.
World J Gastroenterol. 2018 Oct 21;24(39):4489-4498. doi: 10.3748/wjg.v24.i39.4489.
Percutaneous transhepatic extraction and balloon dilation for simultaneous gallbladder stones and common bile duct stones: A novel technique.
Liu B, Wu DS, Cao PK, Wang YZ, Wang WJ, Wang W, Chang HY, Li D, Li X, Hertzanu Y, Li YL.
World J Gastroenterol. 2018 Sep 7;24(33):3799-3805. doi: 10.3748/wjg.v24.i33.3799.
[Preliminary clinical efficacy of percutaneous transcystic papilla balloon dilation for removing common bile duct stones].
Li D, Zhu JR, Hou XQ, Du F, Liu B, Wang WJ, Li YL.
Zhonghua Yi Xue Za Zhi. 2017 Aug 15;97(31):2454-2457. doi: 10.3760/cma.j.issn.0376-2491.2017.31.015.
Intrahepatic bile duct dilatation after percutaneous radiofrequency ablation for hepatocellular carcinoma: impact on patient's prognosis.
Kondo Y, Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Goto E, Nakagawa H, Masuzaki R, Asaoka Y, Fujie H, Goto T, Omata M, Yoshida H, Koike K.
Liver Int. 2011 Feb;31(2):197-205. doi: 10.1111/j.1478-3231.2010.02415.x. Epub 2010 Dec 15.
Risk Factors for Bile Duct Injury After Percutaneous Thermal Ablation of Malignant Liver Tumors: A Retrospective Case-Control Study.
Lin MX, Ye JY, Tian WS, Xu M, Zhuang BW, Lu MD, Xie XY, Kuang M.
Dig Dis Sci. 2017 Apr;62(4):1086-1094. doi: 10.1007/s10620-016-4312-1. Epub 2017 Feb 15.
Long-Term Impact of Iatrogenic Bile Duct Injury.
Schreuder AM, Busch OR, Besselink MG, Ignatavicius P, Gulbinas A, Barauskas G, Gouma DJ, van Gulik TM.
Dig Surg. 2020;37(1):10-21. doi: 10.1159/000496432. Epub 2019 Jan 17.
